Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer?

Results from the Surveillance, Epidemiology, and End Results database published in Cancer. This current population–based observational study suggested a potential survival benefit for adjuvant RT among patients with diffuse–type gastric cancer. The standard treatment will likely remain controversial until evidence becomes available from phase 3 randomized trials exclusively for patients with diffuse–type gastric cancer.

MDLinx